220 related articles for article (PubMed ID: 21128774)
21. The dermal-based borderline melanocytic tumor: a categorical approach.
Magro CM; Crowson AN; Mihm MC; Gupta K; Walker MJ; Solomon G
J Am Acad Dermatol; 2010 Mar; 62(3):469-79. PubMed ID: 20159313
[TBL] [Abstract][Full Text] [Related]
22. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
23. The role of sentinel node biopsy in the management of melanocytic lesions of uncertain malignant potential (MUMP).
McArthur GJ; Banwell ME; Cook MG; Powell BW
J Plast Reconstr Aesthet Surg; 2007; 60(8):952-4. PubMed ID: 17616368
[TBL] [Abstract][Full Text] [Related]
24. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
[TBL] [Abstract][Full Text] [Related]
25. Spitz nevus and atypical spitzoid neoplasm.
Miteva M; Lazova R
Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010
[TBL] [Abstract][Full Text] [Related]
26. Non-sentinel lymph node involvement in a patient with an atypical Spitz tumor and a positive sentinel node. Report of a case and review of the literature.
Urso C; Borgognoni L; Doria M; Tinacci G; Zini E
J Cutan Pathol; 2009 May; 36(5):586-90. PubMed ID: 19476530
[TBL] [Abstract][Full Text] [Related]
27. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
28. S100A6 protein expression is different in Spitz nevi and melanomas.
Ribé A; McNutt NS
Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
[TBL] [Abstract][Full Text] [Related]
29. Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.
Ali L; Helm T; Cheney R; Conroy J; Sait S; Guitart J; Gerami P
Int J Clin Exp Pathol; 2010 Jun; 3(6):593-9. PubMed ID: 20661407
[TBL] [Abstract][Full Text] [Related]
30. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas.
Erickson LA; Letts GA; Shah SM; Shackelton JB; Duncan LM
Mod Pathol; 2009 Jul; 22(7):969-76. PubMed ID: 19396153
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
Chen PL; Chen WS; Li J; Lind AC; Lu D
Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
[TBL] [Abstract][Full Text] [Related]
32. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
33. The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions.
Cochran AJ; Binder S; Morton DL
J Cutan Pathol; 2010 Apr; 37 Suppl 1():54-9. PubMed ID: 20482676
[TBL] [Abstract][Full Text] [Related]
34. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?
Busam KJ; Pulitzer M
Adv Anat Pathol; 2008 Sep; 15(5):253-62. PubMed ID: 18724099
[TBL] [Abstract][Full Text] [Related]
36. Sentinel node biopsy for melanocytic tumors in children.
Kayton ML; La Quaglia MP
Semin Diagn Pathol; 2008 May; 25(2):95-9. PubMed ID: 18697712
[TBL] [Abstract][Full Text] [Related]
37. Pediatric Melanoma and Atypical Melanocytic Neoplasms.
Sreeraman Kumar R; Messina JL; Reed D; Navid F; Sondak VK
Cancer Treat Res; 2016; 167():331-69. PubMed ID: 26601871
[TBL] [Abstract][Full Text] [Related]
38. BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.
Piris A; Mihm MC; Hoang MP
Hum Pathol; 2015 Feb; 46(2):239-45. PubMed ID: 25479927
[TBL] [Abstract][Full Text] [Related]
39. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas.
Busam KJ; Murali R; Pulitzer M; McCarthy SW; Thompson JF; Shaw HM; Brady MS; Coit DG; Dusza S; Wilmott J; Kayton M; Laquaglia M; Scolyer RA
Am J Surg Pathol; 2009 Sep; 33(9):1386-95. PubMed ID: 19609204
[TBL] [Abstract][Full Text] [Related]
40. Atypical Spitz tumours and sentinel lymph node biopsy: a systematic review.
Lallas A; Kyrgidis A; Ferrara G; Kittler H; Apalla Z; Castagnetti F; Longo C; Moscarella E; Piana S; Zalaudek I; Argenziano G
Lancet Oncol; 2014 Apr; 15(4):e178-83. PubMed ID: 24694641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
